Cognitive-Affective Predictors of the Uptake of, and Sustained Adherence to, Lymphedema Symptom Minimization Practices in Breast Cancer Survivors
Abstract
Approximately 20-30% of women develop lymphedema (LE) following breast cancer treatment; this condition has been associated with psychological distress and diminished quality of life. Effective symptom management requires that women not only recognize early signs of this condition, but that they uptake and maintain precautionary practices over their lifetime. Yet, the limited data available indicate that knowledge and use of symptom minimization precautions are poor, particularly over time. Unfortunately, little is known about how breast cancer survivors perceive their LE risk status, and the cognitive-affective factors that promote the uptake of; and adherence to, LE symptom minimization precautions. Further, the moderating role of individual differences in attentional style has not been explored. Guided by the Cognitive-Social Health Information Processing (C-SHIP) model, we will conduct a longitudinal study, to assess the barriers and facilitators associated with knowledge about, and adherence to, LE symptom-minimization practices among breast cancer survivors currently unaffected by LE. We will explore the mediating role of cognitive-affective variables, and the moderating role of attentional style, on knowledge, uptake and adherence over time. Toward this end, we will survey levels of knowledge, and the practice of symptom minimization precautions at baseline, and again at 6-, and 12-month follow-up.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2004
- Accession Number
- ADA431794
Entities
People
- Suzanne M. Miller
Organizations
- Fox Chase Cancer Center